|
| 产地 | 美国 |
| 品牌 | SCRSTANDARD |
| 货号 | SCSI-323123 |
| 用途 | 科研用 |
| 包装规格 | 1g |
| CAS编号 | 461670-12-2 |
| 纯度 | 98% |
| 是否进口 | 是 |
| 货号 | 英文品名 | 英文品名 | CAS |
| SCSI-323123 | [D3]BRASSINOLIDE(D-BI) [[26-D3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestan-6-one] | [D3]BRASSINOLIDE(D-BI) [[26-D3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestan-6-one] | 461670-12-2 |
| SCSI-323124 | [D3]EPIBRASSINOLIDE(D-EBI) [[D3]24-epibrassinolide, [26-D3],(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one] | [D3]EPIBRASSINOLIDE(D-EBI) [[D3]24-epibrassinolide, [26-D3],(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one] | 1316216-51-9 |
| SCSI-323125 | [D3]BRASSINONE (D-NBk) [[D3] 28-norcastasterone, [26-D3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-5α-cholestan-6-one] | [D3]BRASSINONE (D-NBk) [[D3] 28-norcastasterone, [26-D3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-5α-cholestan-6-one] | 1632494-67-7 |
| SCSI-323126 | [D3]CASTASTERONE(D-Bk) [[26-D3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestan-6-one] | [D3]CASTASTERONE(D-Bk) [[26-D3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestan-6-one] | 461670-13-3 |
| SCSI-323127 | [D3]EPICASTASTERONE (D-EBk) [[D3] 24-epicastasterone, [26-D3] (22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one] | [D3]EPICASTASTERONE (D-EBk) [[D3] 24-epicastasterone, [26-D3] (22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one] | 1316216-47-3 |
| SCSI-323128 | [D3]CAMPESTANOL (D-CAMP) [[26-D3](24R)-3-β-hydroxy-24-methyl-5α-cholestane] | [D3]CAMPESTANOL (D-CAMP) [[26-D3](24R)-3-β-hydroxy-24-methyl-5α-cholestane] | 1400878-56-9 |
| SCSI-323129 | [D3]CATHASTERONE (D-CATH) [[22,26,26-D3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane-6-one] | [D3]CATHASTERONE (D-CATH) [[22,26,26-D3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane-6-one] | 1380235-47-1 |
| SCSI-323130 | [D3]6-DEOXO-24-EPICASTASTERONE (D-EBd) [[26-D3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane] | [D3]6-DEOXO-24-EPICASTASTERONE (D-EBd) [[26-D3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane] | 1402912-18-8 |
| SCSI-323131 | [D3]6-DEOXOCASTASTERONE (D-6deoxoCS) [[26-D3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane | [D3]6-DEOXOCASTASTERONE (D-6deoxoCS) [[26-D3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane | 1402912-18-8 |
| SCSI-323132 | [D3]6-DEOXYTYPHASTEROL (2H-6deoxoTY) [[26-D3](3α,5α22R,23R,24S)-Ergostane-3,22,23-triol | [D3]6-DEOXYTYPHASTEROL (2H-6deoxoTY) [[26-D3](3α,5α22R,23R,24S)-Ergostane-3,22,23-triol | 1449510-51-3 |
| SCSI-323133 | [D3]6-DEOXYTYPHASTEROL (D-DECATH) [[26-D3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane] | [D3]6-DEOXYTYPHASTEROL (D-DECATH) [[26-D3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane] | 1449510-51-3 |
| SCSI-323134 | [D3]CAMPESTEROL (D-CR) [[26-D3](3S,8S,9S10R14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopentaphenanthren-3-ol] | [D3]CAMPESTEROL (D-CR) [[26-D3](3S,8S,9S10R14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopentaphenanthren-3-ol] | 1400878-52-5 |
| SCSI-323135 | [D3]NORBRASSINOLIDE (D-NBI) [[D3] 28-norbrassinolide, [26-D3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-B-homo-7-oxa-5α-cholestan-6-one] | [D3]NORBRASSINOLIDE (D-NBI) [[D3] 28-norbrassinolide, [26-D3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-B-homo-7-oxa-5α-cholestan-6-one] | 313350-52-6 |
| SCSI-323136 | [D3]TYPHASTEROL (D-TY) [[26-D3] 3,22,23-trihydroxy-(3α,5α,22R,23R,24S)-Ergostan-6-one] | [D3]TYPHASTEROL (D-TY) [[26-D3] 3,22,23-trihydroxy-(3α,5α,22R,23R,24S)-Ergostan-6-one] | 461670-14-4 |
T: 021-58000709
